People · Operator
Named in public records as an officer, director or promoter · active 2014–2021 · Other Health Care, Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| NotalVision, Inc. | — | Other Health Care | Series B | $16.4M | $271.9M | 2021 |
| Mosaic Biosciences, Inc. | — | Biotechnology | Series A | $14.7M | $176.1M | 2014 |
| Saiva, Inc. | — | Other Technology | Pre-Seed | $500K | $21.2M | 2018 |
Guy Katsav at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Guy Katsav on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John Hall | 1 | 11 |
| Augustine Lawlor | 1 | 8 |
| Mark Lupa | 1 | 5 |
| Nassim Usman | 1 | 4 |
| Quinton Oswald | 1 | 3 |
| Eric Furfine | 1 | 3 |
| Jeanette Welsh | 1 | 3 |
| Rob Capone | 1 | 2 |
| Zvika Slovin | 1 | 2 |
| Dan Mitchell | 1 | 2 |
| Anat Loewenstein | 1 | 1 |
| Barak Azmon | 1 | 1 |
| Eliot Lazar, MD | 1 | 1 |
| Martin Stanton | 1 | 1 |
| Jason Strober | 1 | 1 |
| Kester Nahen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.